These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37060359)

  • 1. CX
    Cabana-Puig X; Lu R; Geng S; Michaelis JS; Oakes V; Armstrong C; Testerman JC; Liao X; Alajoleen R; Appiah M; Zhang Y; Reilly CM; Li L; Luo XM
    Inflamm Res; 2023 May; 72(5):1083-1097. PubMed ID: 37060359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
    Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide.
    Imaruoka K; Oe Y; Fushima T; Sato E; Sekimoto A; Sato H; Sugawara J; Ito S; Takahashi N
    Biochem Biophys Res Commun; 2019 Mar; 510(4):587-593. PubMed ID: 30739788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
    Hoi AY; Hickey MJ; Hall P; Yamana J; O'Sullivan KM; Santos LL; James WG; Kitching AR; Morand EF
    J Immunol; 2006 Oct; 177(8):5687-96. PubMed ID: 17015758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus.
    Jin X; Chen J; Wu J; Lu Y; Li B; Fu W; Wang W; Cui D
    Front Immunol; 2022; 13():928359. PubMed ID: 36119056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 regulates murine lupus.
    Yin Z; Bahtiyar G; Zhang N; Liu L; Zhu P; Robert ME; McNiff J; Madaio MP; Craft J
    J Immunol; 2002 Aug; 169(4):2148-55. PubMed ID: 12165544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.
    Ju ZL; Shi GY; Zuo JX; Zhang JW;
    Immunology; 2007 Feb; 120(2):281-9. PubMed ID: 17073941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with lysophosphatidic acid improves glomerulonephritis through the suppression of macrophage activation in a murine model of systemic lupus erythematosus.
    Nagata W; Takayama E; Nakagawa K; Koizumi A; Ohsawa Y; Goto H; Yamashiro A; Ishinoda Y; Tanoue K; Kumagai H; Oshima N; Ishizuka T
    Clin Exp Rheumatol; 2024 Mar; 42(3):658-665. PubMed ID: 38436267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
    Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
    J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of heterozygous lpr gene in MRL mice. II. Acceleration of glomerulonephritis, sialadenitis, and autoantibody production.
    Carlsten H; Tarkowski A; Jonsson R; Nilsson LA
    Scand J Immunol; 1990 Jul; 32(1):21-8. PubMed ID: 2382106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of inducible costimulator in the development of lupus in MRL/lpr mice.
    Tada Y; Koarada S; Tomiyoshi Y; Morito F; Mitamura M; Haruta Y; Ohta A; Nagasawa K
    Clin Immunol; 2006 Aug; 120(2):179-88. PubMed ID: 16616645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota mediated the effects of high relative humidity on lupus in female MRL/lpr mice.
    Wang C; Lin Y; Chen L; Chen H
    Adv Rheumatol; 2023 May; 63(1):24. PubMed ID: 37217962
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Alajoleen RM; Oakland DN; Estaleen R; Shakeri A; Lu R; Appiah M; Sun S; Neumann J; Kawauchi S; Cecere TE; McMillan RP; Reilly CM; Luo XM
    Front Immunol; 2024; 15():1359534. PubMed ID: 38352866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
    J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
    J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies.
    Liang B; Gee RJ; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 1999 Aug; 163(4):2322-9. PubMed ID: 10438978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus.
    Sekine H; Graham KL; Zhao S; Elliott MK; Ruiz P; Utz PJ; Gilkeson GS
    J Immunol; 2006 Nov; 177(10):7423-34. PubMed ID: 17082662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.
    Yasuda K; Watkins AA; Kochar GS; Wilson GE; Laskow B; Richez C; Bonegio RG; Rifkin IR
    PLoS One; 2014; 9(7):e103478. PubMed ID: 25076492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.